Current approaches to targeting cancer using antiangiogenesis therapies

Folkman, 1992, Angiogenesis, J. Biol. Chem., 267, 10931, 10.1016/S0021-9258(19)49853-0 Folkman, 1990, What is the evidence that tumors are angiogenesis dependent?, J. Natl Cancer Inst, 82, 4, 10.1093/jnci/82.1.4 Hobson, 1984, Endothelial proliferation in tumours and normal tissues: continuous labelling studies, Br. J. Cancer, 49, 405, 10.1038/bjc.1984.66 Fox, 1993, Relationship of endothelial cell proliferation to tumour vascularity in human breast cancer, Cancer Res., 53, 4161 Folkman, 1971, Tumour angiogenesis: therapeutic implications, N. Eng. J. Med., 285, 1182, 10.1056/NEJM197111182852108 Denekamp, 1993, Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy, Br. J. Radiol., 66, 181, 10.1259/0007-1285-66-783-181 Folkman, 1985, Tumour angiogenesis, Adv. Cancer Res, 43, 175, 10.1016/S0065-230X(08)60946-X Denekamp, 1992, Inadequate vasculature in solid tumours: consequences for cancer research strategies, Br. J. Radiol., 24, 111 Folkman, 1991, Switch to the angiogenic phenotype during tumorigenesis, 22, 339 McLeskey, 1993, Fibroblast growth factor-iv transfection of mcf-7 cells produces cell-lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude-mice, Cancer Res, 53, 2168 Ueki, 1993, Potentiation of metastatic capacity by transforming growth-factor-beta-1 gene transfection, Jpn J. Cancer Res., 84, 589, 10.1111/j.1349-7006.1993.tb02017.x Kim, 1993, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature, 362, 841, 10.1038/362841a0 Weidner, 1992, Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma, J. Natl Cancer Inst., 84, 1875, 10.1093/jnci/84.24.1875 Horak, 1992, Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastasis and survival in breast cancer, Lancet, 340, 1120, 10.1016/0140-6736(92)93150-L Fox, 1994, Tumor angiogenesis in node negative breast carcinomas-relationship with epidermal growth factor receptor, estrogen receptor and survival, Breast Cancer Res. Treat., 29, 109, 10.1007/BF00666186 Chodak, 1980, Angiogenic activity as a marker of neoplasia and preneoplasia in lesions of the human bladder, Ann. Surg., 192, 762, 10.1097/00000658-198012000-00012 Vacca, 1993, Melanocyte tumour progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor, Cancer, 72, 455, 10.1002/1097-0142(19930715)72:2<455::AID-CNCR2820720222>3.0.CO;2-8 Sillman, 1981, The significance of atypical vessels and neovascularisation in cervical neoplasia, Am. J. Obstet. Gynecol., 139, 154, 10.1016/0002-9378(81)90438-5 Teicher, 1992, Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease, Cancer Res., 52, 6702 Pienta, 1993, Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide, Cancer Res., 53, 224 Takamiya, 1993, Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM 1470, J. Neurosurg., 78, 470, 10.3171/jns.1993.78.3.0470 Folkman, 1992, Inhibition of angiogenesis, Semin. Cancer Biol., 3, 89 Bicknell, 1991, Novel growth regulatory factors and tumour angiogenesis, Eur. J. Cancer, 27, 781, 10.1016/0277-5379(91)90189-K Bouck, 1993, Angiogenesis: a mechanism by which oncogenes and tumour suppressor genes regulate, 359 Folkman, 1987, Angiogenic factors, Science, 235, 442, 10.1126/science.2432664 Gimbrone, 1974, Tumor growth and neovascularization: an experimental model using the rabbit cornea, J. Natl Cancer Inst., 52, 413, 10.1093/jnci/52.2.413 Nguyen, 1993, Elevated levels of the angiogenic peptide basic fibroblast growth-factor in urine of bladder-cancer patients, J. Natl Cancer Inst., 85, 241, 10.1093/jnci/85.3.241 Folkman, 1993, Tumor angiogenesis: diagnostic and therapeutic clinical implications, American Association for Cancer Research, 34, 571 Vlodavsky, 1991, Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis, J. Cell Biochem., 45, 167, 10.1002/jcb.240450208 Berkman, 1993, Expression of the vascular permeability factor/vascular endothelial growth factor gene in the central nervous system neoplasms, J. Clin. Invest., 91, 153, 10.1172/JCI116165 Berse, 1992, Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors, Mol. Biol. Cell, 3, 211, 10.1091/mbc.3.2.211 Ferrara, 1992, Molecular and biological properties of the vascular endothelial growth factor family of proteins, Endocr. Rev., 13, 18, 10.1210/edrv-13-1-18 Millauer, 1994, Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant, Nature, 367, 576, 10.1038/367576a0 Braddock, 1994, A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions, Br. J. Can., 69, 890, 10.1038/bjc.1994.172 Gagliardi, 1993, Inhibition of angiogenesis by antiestrogens, Cancer Res., 53, 533 Zugmaier, 1992, Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumour cells and blockage by PPS of tumor growth in animals, J. Natl Cancer Inst., 84, 1716, 10.1093/jnci/84.22.1716 Siegall, 1991, Cytotoxic activity of chimeric proteins composed of acidic fibroblast growth factor and Pseudomonas exotoxin on a variety of cell types, FASEB J., 5, 2843, 10.1096/fasebj.5.13.1717336 Merwin, 1992, Acidic fibroblast growth factor-Pseudomonas exotoxin chimeric protein elicits antiangiogenic effects on endothelial cells, Cancer Res., 52, 4995 Biro, 1992, In vitro effects of a recombinant toxin targeted to the fibroblast growth factor receptor on rat vascular smooth muscle and endothelial cells, Circ. Res., 71, 640, 10.1161/01.RES.71.3.640 Thorpe, 1993, Heparin-steroid conjugates-new angiogenesis inhibitors with antitumoractivity in mice, Cancer Res, 53, 3000 Nicosia, 1991, Regulation of angiogenesis in vitro by collagen metabolism, In Vitro Cell Dev. Biol., 27A, 961, 10.1007/BF02631124 Orlidge, 1987, Inhibition of capillary endothelial cell growth by pericytes and smooth muscles, J. Cell Biol., 105, 1455, 10.1083/jcb.105.3.1455 Tolsma, 1993, Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity, J. Cell Biol., 122, 497, 10.1083/jcb.122.2.497 Rastinejad, 1989, Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene, Cell, 56, 345, 10.1016/0092-8674(89)90238-9 Good, 1990, A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin, 87, 6624 Tryggvason, 1987, Proteolytic degradation of extracellular matrix in tumour invasion, Biochim. Biophys. Acta., 907, 191 Del Vecchio, 1993, Urokinase and urokinase receptor overexpression in breast carcinoma as compared to benign lesions, American Association for Cancer Research, 34, 64 Liotta, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation, Cell, 64, 327, 10.1016/0092-8674(91)90642-C Eisenstein, 1973, The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularised mesenchyme, Am. J. Pathol., 73, 765 Brem, 1975, Inhibitor of tumor angogenesis mediated by cartilage, J. Exp. Med., 141, 427, 10.1084/jem.141.2.427 Moses, 1992, Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes, J. Cell Biol., 119, 475, 10.1083/jcb.119.2.475 Moses, 1990, Identification of an inhibitor of neovascularization from cartilage, Science, 248, 1408, 10.1126/science.1694043 Pepper, 1991, Chondrocytes inhibit endothelial cell sprout formation in vitro: evidence for the involvement of transforming growth factor- beta, J. Cell Physiol., 146, 170, 10.1002/jcp.1041460122 Takigawa, 1989, Establishment from mouse growth cartilage of clonal cell lines with responsiveness of parathyroid hormone, alkaline phosphatase activity, and ability to produce an endothelial cell growth inhibitor, Calcif. Tissue Int., 45, 305, 10.1007/BF02556024 Tamargo, 1991, Angiogenesis inhibition by minocycline, Cancer Res., 51, 672 Guerin, 1992, Selective endothelial growth inhibition by tetracyclines that inhibit collagenase, Biochem. Biophys. Res. Commun., 188, 740, 10.1016/0006-291X(92)91118-A Sakamoto, 1991, Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2, Cancer Res., 51, 903 Iwamoto, 1987, YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation, Science, 238, 1132, 10.1126/science.2961059 Teusher, 1984, A possible explanation of mechanisms inducing inhibition of vascularisation of tumours by antifibrinolytic drugs-the influence of migratory behaviour of endothelial cells, Biomed. Biochim. Acta., 4, 447 Ingber, 1992, Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy, Sem. Cancer Biol., 3, 57 Maragoudakis, 1993, Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties, Kidney lnt., 43, 147, 10.1038/ki.1993.24 Crum, 1985, A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment, Science, 230, 1375, 10.1126/science.2416056 Taylor, 1982, Protamine is an inhibitor of angiogenesis, Nature, 297, 307, 10.1038/297307a0 White, 1989, Treatment of pulmonary haemangiomatosis with recombinant interferon alpha-2a, N. Engl. J. Med., 320, 1197, 10.1056/NEJM198905043201807 Ezekowitz, 1992, Interferon alpha 2a therapy for life-threatening haemangiomas of infancy, N. Engl. J. Med., 326, 1456, 10.1056/NEJM199205283262203 Lippman, 1992, 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squmous cell carcinoma of the skin, J. Natl. Cancer Inst., 84, 235, 10.1093/jnci/84.4.235 Lippman, 1992, 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix, J. Natl. Cancer Inst., 84, 241, 10.1093/jnci/84.4.241 Clarke, 1991, The identification of proliferation- related proteins in human endothelial cells as a possible target in tumour therapy, Int. J. Radiat. Biol., 60, 17, 10.1080/09553009114551431 Clarke, 1991, The identification of proliferation and tumour-induced proteins in human endothelial cells: a possible target for tumour therapy, Electrophoresis, 12, 500, 10.1002/elps.1150120708 Ingber, 1990, Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth, Nature, 348, 555, 10.1038/348555a0 Brem, 1993, Analysis of experimental antiangiogenesis therapy, J. Pediatr. Surg., 28, 445, 10.1016/0022-3468(93)90246-H Kamei, 1993, Antitumour effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution, J. Pharmacol. Exp. Ther., 264, 469 Toi, 1993, Antitumor effect of the angiogenesis inhibitor agm-1470 and its combination effect with tamoxifen in dmba induced mammary-tumors in rats, Int. J. Oncol., 3, 525 Yamaoka, 1993, Inhibition of tumor-growth and metastasis of rodent tumors by the angiogenesis inhibitor o-(chloroacetylcarbamoyl)fumagillol (tnp-470, agm-1470), Cancer Res., 53, 4262 Maione, 1990, Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides, Science, 247, 77, 10.1126/science.1688470 Oikawa, 1990, Inhibition of angiogenesis by vitamin D3 analogues, Eur. J. Pharmacol., 178, 247, 10.1016/0014-2999(90)90483-M Rogelj, 1988, Basic fibroblast growth factor fused to a signal peptide transforms cells, Nature, 331, 173, 10.1038/331173a0 Houck, 1991, The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing, Mol. Endocrinol, 5, 1806, 10.1210/mend-5-12-1806 Unemori, 1992, Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells, J. Cell Physiol., 153, 557, 10.1002/jcp.1041530317 Maglione, 1993, Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14, Oncogene, 8, 925 Fang, 1992, Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer, J. Biol. Chem., 267, 25889, 10.1016/S0021-9258(18)35692-8 Schreiber, 1986, Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor, Science, 232, 1250, 10.1126/science.2422759 Rosen, 1993, The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis, EXS, 65, 301 Hockel, 1987, Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and ‘tube formation’ but not proliferation of capillary endothelial cells in vitro, J. Cell Physiol., 133, 1, 10.1002/jcp.1041330102 Stetler-Stevenson, 1989, Tissue inhibitor of metalloproteinase (TIMP 2), J. Biol. Chem., 264, 17374, 10.1016/S0021-9258(18)71503-2 Iruela-Arispe, 1991, Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro, 88, 5026 Vogel, 1993, Modulation of endothelial-cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type-1 repeats of thrombospondin, J. Cell Biochem., 53, 74, 10.1002/jcb.240530109 Pesenti, 1992, Suramin prevents neovascuoularisation and tumour growth through blocking of basic fibroblast growth factor activity, Br. J. Cancer, 66, 367, 10.1038/bjc.1992.272 Tanaka, 1989, Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid, Cancer Res., 49, 6727 Nguyen, 1993, Pentosan inhibits angiogenesis in vitro and this appearsto correlate with the inhibition of prostate tumor associated angiogenesis in vivo, American Association for Cancer Research, 34, 75 Uehara, 1988, Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A, Virology, 164, 294, 10.1016/0042-6822(88)90649-6 Oikawa, 1989, Powerful antiangiogenic activity of herbimycin A (named angiostatic antibiotic), J. Antibiot., 42, 1202, 10.7164/antibiotics.42.1202 Brem, 1990, Inhibition of angiogenesis and tumor growth in the brain, Am. J. Pathol., 137, 1121 Gately, 1993, D-Penicillamine, a novel antiglioma agent, selectively suppresses endothelial growth and migration, American Association for Cancer Research, 34, 375 Polakowski, 1993, A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice, Am. J. Pathol., 143, 507 Tanaka, 1991, The combination of a bacterial polysaccharide and tamoxifen inhibits angiogenesis and tumour growth, Int. J. Radiat. Biol., 60, 79, 10.1080/09553009114551601 Wright, 1992, Inhibition of angiogenesis in vitro and in ovo with an inhibitor of cellular protein kinases, MDL 27032, J. Cell. Physiol., 152, 448, 10.1002/jcp.1041520303 Fotsis, 1993, Genistein, a dietary-derived inhibitor of in vitro angiogenesis, 90, 2690 Kusaka, 1991, Potent antiangiogenic action of AGM-1470: comparison to fumagillin, Biochem. Biophys. Res. Commun., 174, 1070, 10.1016/0006-291X(91)91529-L Ingber, 1988, Inhibition of angiogenesisthrough modulation of collagen metabolism, Lab. Invest., 59, 44 Moon, 1979, N-4-Hydroxyphenyl retinamide, a new retinoid for prevention of breast cancer in the rat, Cancer Res., 39, 1339 Costa, 1989, Tolerability of the synthetic retinoid fenretinide (HPR), Eur. J. Cancer Clin. Oncol., 25, 805, 10.1016/0277-5379(89)90124-7 Peng, 1989, Pharmacokinetics of N-4 hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients, Int. J. Cancer, 43, 22, 10.1002/ijc.2910430106 Oikawa, 1991, Antitumor effect of 22-oxa-lalpha, 25 dihydroxyvitamin D3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7, 12-dimethylbenz [a]anthracene, Anti-Cancer Drugs, 2, 475, 10.1097/00001813-199110000-00007 Eisman, 1993, Vitamin D and cancer cell replication, American Association for Cancer Research, 34, 620 Oikawa, 1991, Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor, Biochem. Biophys. Res. Commun., 181, 1070, 10.1016/0006-291X(91)92046-M Guyer, 1992, Systemic antiangiogenic therapy for choroidal neovascularization, Arch. Ophthalmol., 110, 1383, 10.1001/archopht.1992.01080220045019 Ribatti, 1993, Anti-angiogenesis: a multipurpose therapeutic tool?, Int. J. Clin. Lab. Res., 23, 117, 10.1007/BF02592295 Oikawa, 1992, Effect of 15-deoxyspergualin, a microbial angiogenesis inhibitor, on the biological activities of bovine vascular endothelial cells, AntiCancer Drugs, 3, 293, 10.1097/00001813-199206000-00014 Clapp, 1993, The 16kDa N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis, Endocrinology, 133, 1292, 10.1210/en.133.3.1292 Ferrara, 1991, The 16K fragment of prolactin specifically inhibits basal or FGF stimulated growth of capillary endothelial cells, Endocrinology, 129, 896, 10.1210/endo-129-2-896 Danesi, 1993, Octreotide inhibits endothelial proliferation and angiogenesis in the chick chorioallantoic membrane and the rat cornea, American Association for Cancer Research, 34, 354 Breslow, 1993, Captopril inhibits C6 glioma and endothelial cell growth and proliferation in vitro, American Association for Cancer Research, 34, 375 Ward, 1993, Captopril inhibits endothelial-cell migration in vitro and angiogenesis in vivo, FASEBJ, 7 Lindsay, 1993, Flavone acetic acid inhibits endothelial growth in the absence of cytotoxicity, American Association for Cancer Research, 34, 436 Vukanovic, 1993, Antiangiogenic effects of the quinolone-3-carboxamide linomide, Cancer Res., 53, 1833